EMPLOYMENT AGREEMENTEmployment Agreement • February 26th, 2018 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 26th, 2018 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made as of the DATE by and between NAME, on the one hand (the “Executive”), and VBI Vaccines (Delaware) Inc., a Delaware corporation (the “Company”), on the other hand.
AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • February 26th, 2018 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • Ontario
Contract Type FiledFebruary 26th, 2018 Company Industry JurisdictionThis Amendment to Consulting Agreement (the “Amendment”), effective as of January, 1th, 2018 (the “Effective Date”), is by and between Variation Biotechnologies Inc., a corporation incorporated pursuant to the laws of Canada (the “Company”) having an address of 310 Hunt Club Road East, Ottawa, Ontario K1V 1C1 and F. Diaz-Mitoma Professional Corporation (Ontario corporation number 002356634) having an address of 210 Barrow Crescent, Kanata, Ontario K2L 2C7 (“Consultant”). The Consultant and Company are sometimes referred to as a “Party” and are collectively referred to as the “Parties”.
WAIVER AGREEMENTWaiver Agreement • February 26th, 2018 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 26th, 2018 Company Industry JurisdictionTHIS WAIVER AGREEMENT (this “Agreement”), dated as of February 21, 2018, is entered into by and among VARIATION BIOTECHNOLOGIES (US), INC., a Delaware corporation (the “Borrower”); the Guarantors identified under the caption “GUARANTORS” on the signature pages hereto, and Perceptive Credit Holdings, LP, a Delaware limited partnership (the “Lender”). Terms used herein without definition shall have the meanings ascribed to them in the Credit Agreement defined below.
Agreement to Extend the Lease of an Unprotected Leased Premises of January 16, 2017 Which was written and signed on January 21st, 2018VBI Vaccines Inc/Bc • February 26th, 2018 • Pharmaceutical preparations
Company FiledFebruary 26th, 2018 IndustryWhereas: On November 5th, 2013 Ayalot Investments (Ramat Vered) 1994 Ltd. and Sharda Ltd. (hereinafter collectively referred to as the “Original Lessor”) signed a Main Lease Agreement including all appendixes thereof with the Company with respect to the leased premises (the Main Lease Agreement including all appendixes thereof shall be referred to hereinafter as the “Main Lease Agreement”);